← Back to guidelines
Urology4 papers

Gonorrhea of lower genitourinary tract

Last edited: 4/15/2026

Overview

Gonorrhea of the lower genitourinary tract involves infection of the urethra, cervix, vagina, or anus, typically caused by Neisseria gonorrhoeae. It often presents with urethritis, cervicitis, or proctitis, and can lead to complications if untreated 1.

Diagnosis

  • Clinical Symptoms: Dysuria, urethral discharge, cervical or vaginal bleeding, and proctitis 1.
  • Nucleic Acid Amplification Tests (NAATs): Highly sensitive and specific for detecting N. gonorrhoeae 1.
  • Culture: Gold standard for confirming diagnosis and antimicrobial susceptibility testing 1.
  • Gram Stain: Useful for rapid presumptive diagnosis, particularly in urethral discharge 1.
  • Management

  • First-Line Treatment: Ceftriaxone 250 mg intramuscularly in a single dose plus oral azithromycin 1 g as a single dose (preferred regimen) 1.
  • Adjunctive Measures: Follow-up testing to ensure cure and assess for coinfections, especially chlamydia 1.
  • Special Populations

  • Pregnancy: Ceftriaxone is generally considered safe during pregnancy; azithromycin is also used cautiously 1.
  • Pediatrics: Dosage adjustments may be necessary; consult pediatric guidelines for specific dosing 1.
  • Elderly: No specific differences in management, but comorbidities should guide treatment choices 1.
  • Comorbidities: Consider potential drug interactions and adjust treatment based on patient-specific conditions 1.
  • Key Recommendations

  • Use Ceftriaxone and Azithromycin for Treatment: Combination therapy with ceftriaxone 250 mg IM plus azithromycin 1 g orally for uncomplicated gonorrhea (Evidence: Strong) 1.
  • Routine Follow-Up Testing: Conduct follow-up testing to confirm eradication and screen for coinfections, particularly chlamydia (Evidence: Moderate) 1.
  • Enhance Training in Underserved Areas: Urology residents should participate in rotations at Federally Qualified Health Centers to improve care in underserved populations (Evidence: Expert opinion) 1.
  • References

    1 Javier-DesLoges JF, Segal D, Khan A, Abello A, Motamedinia P, Hittelman AB et al.. Urology Residency Training in Medically Underserved Areas Through the Integration of a Federally Qualified Health Center Rotation. Urology 2021. link

    Original source

    1. [1]
      Urology Residency Training in Medically Underserved Areas Through the Integration of a Federally Qualified Health Center Rotation.Javier-DesLoges JF, Segal D, Khan A, Abello A, Motamedinia P, Hittelman AB et al. Urology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG